MAPK1 and glioblastoma: Our results also showed that knockdown of SEPT9 or SEPT2 in GBM cells reduces the activation of MEK/ERK pathway (Figs. 7a, e), which contributes to GBM cell proliferation, migration, invasion, and tumor formation in vivo61.